Related references
Note: Only part of the references are listed.Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma
Raelene Endersby et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Emerging Roles of SKP2 in Cancer Drug Resistance
Ting Wu et al.
CELLS (2021)
p27Kip1, an Intrinsically Unstructured Protein with Scaffold Properties
Debora Bencivenga et al.
CELLS (2021)
Targeting DNA repair pathway in cancer: Mechanisms and clinical application
Manni Wang et al.
MEDCOMM (2021)
Targeting the replication stress response through synthetic lethal strategies in cancer medicine
Natalie Y. L. Ngoi et al.
TRENDS IN CANCER (2021)
Comparison of the different mechanisms of cytotoxicity induced by checkpoint kinase I inhibitors when used as single agents or in combination with DNA damage
Nicholas J. H. Warren et al.
ONCOGENE (2020)
The Skp2 Pathway: A Critical Target for Cancer Therapy
Zhen Cai et al.
SEMINARS IN CANCER BIOLOGY (2020)
SAFB2 Enables the Processing of Suboptimal Stem-Loop Structures in Clustered Primary miRNA Transcripts
Katharina Hutter et al.
MOLECULAR CELL (2020)
CHK1 Inhibitor Blocks Phosphorylation of FAM122A and Promotes Replication Stress
Feng Li et al.
MOLECULAR CELL (2020)
Checkpoint kinase 1 is essential for fetal and adult hematopoiesis
Fabian Schuler et al.
EMBO REPORTS (2019)
Basal CHK1 activity safeguards its stability to maintain intrinsic S-phase checkpoint functions
Jone Michelena et al.
JOURNAL OF CELL BIOLOGY (2019)
Inhibition of checkpoint kinase 1 following gemcitabine-mediated S phase arrest results in CDC7-and CDK2-dependent replication catastrophe
Nicholas J. H. Warren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Chk1-mediated Cdc25A degradation as a critical mechanism for normal cell cycle progression
Hidemasa Goto et al.
JOURNAL OF CELL SCIENCE (2019)
Checkpoint kinase 1 is essential for normal B cell development and lymphomagenesis
Fabian Schuler et al.
NATURE COMMUNICATIONS (2017)
Loss of BIM augments resistance of ATM-deficient thymocytes to DNA damage-induced apoptosis but does not accelerate lymphoma development
Alex R. D. Delbridge et al.
CELL DEATH AND DIFFERENTIATION (2017)
Caspases uncouple p27Kip1 from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion
S. R. Podmirseg et al.
ONCOGENE (2016)
CHK1 as a therapeutic target to bypass chemoresistance in AML
Laure David et al.
SCIENCE SIGNALING (2016)
CHK1 as a therapeutic target to bypass chemoresistance in AML
Laure David et al.
SCIENCE SIGNALING (2016)
Not All DDRs Are Created Equal: Non-Canonical DNA Damage Responses
Rebecca C. Burgess et al.
CELL (2015)
DNA damage control: regulation and functions of checkpoint kinase 1
Veronique A. J. Smits et al.
FEBS JOURNAL (2015)
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma
Enrico Derenzini et al.
ONCOTARGET (2015)
Roles of Chk1 in cell biology and cancer therapy
Youwei Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Death of p53-defective cells triggered by forced mitotic entry in the presence of DNA damage is not uniquely dependent on Caspase-2 or the PIDDosome
C. Manzl et al.
CELL DEATH & DISEASE (2013)
CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma
Jian Hong et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells
Andreas Hoeglund et al.
CLINICAL CANCER RESEARCH (2011)
Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs
Luis I. Toledo et al.
MOLECULAR ONCOLOGY (2011)
The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor-/progesterone receptor-/HER-2-: Breast carcinomas
Lieve Verlinden et al.
CANCER RESEARCH (2007)
p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage
H. Christian Reinhardt et al.
CANCER CELL (2007)
p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2
Isabel Chu et al.
CELL (2007)
Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases
Matthias Grimmler et al.
CELL (2007)
p27Kip1 modulates cell migration through the regulation of RhoA activation
A Besson et al.
GENES & DEVELOPMENT (2004)
p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa
A Villunger et al.
SCIENCE (2003)
PUMA mediates the apoptotic response to p53 in colorectal cancer cells
J Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
PUMA induces the rapid apoptosis of colorectal cancer cells
J Yu et al.
MOLECULAR CELL (2001)
Rapid destruction of human Cdc25A in response to DNA damage
N Mailand et al.
SCIENCE (2000)
Share Paper
